3rd International Definiens Symposium to be Held in Munich from June 14-16, 2012
Published: Monday, April 23, 2012 Last Updated: Monday, April 23, 2012
Program features latest trends in quantitative digital pathology and tissue-based biomarker development with leading experts from Roche, AstraZeneca, Novartis and cutting-edge biomedical image and data analysis during hands-on workshops.
Full access to this article is for registered users only. Registration is free-of-charge and allows access to all content on our web communities.
Already registered? Then please log in at the top of the page.